TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05196009

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth peer navigation and social support
Description: Peer navigation, asynchronous support via SMS, Motivational Interviewing, virtual social support group focused on mental health and substance use, linkage and follow-up
Study: NCT05556304

Intervention type: OTHER
Group type: OTHER
Intervention: assessment in the 8th month of pregnancy and during delivery
Description: * Day 0: presentation of the study~* During pregnancy between Day 0 and 36-38SA: inclusion~* During pregnancy: collection of pelvic MRI data if performed during pregnancy for maternal or fetal reasons~* Between 36 and 38 WG: collection of demographic, obstetrical, fetal ultrasound and clinical data / Perineal elastographic recording / Recording of the perineal deformation by stereovision camera~* In the delivery room, at the beginning of labor and before pushing: collection of clinical data / Collection of obstetrical ultrasound data / Perineal elastographic recordings / Recording of the perineal deformation by stereovision camera~* In the delivery room, during expulsion : recording of the perineal deformation by stereovision camera~* In the delivery room, after childbirth: collection of obstetrical, clinical and neonatal data / Perineal elastographic recordings / Cephalic and shoulder measurements of the newborn with a tape measure
Study: NCT05407961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Description: Administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dulaglutide
Description: Administered SC.
Study: NCT05613582

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.
Study: NCT05476094

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Polyene Phosphatidylcholine
Description: AYP-101 1 - 25 mg of essential phospholipids in 1 mL AYP-101 2 - 50 mg of essential phospholipids in 1 mL Placebo - Essential phospholipids in 1 mL 00 mg
Study: NCT05190406

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulpotomy
Description: After achieving hemostasis, in pulpotomy group bioceramic material will be placed and then permanent restoration will be done.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: root canal treatment
Description: Single visit root canal treatment will be done according to standard protocol.
Study: NCT05613582

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: The flow of DC electric current 1 mA for 20 minutes. The position of the electrode placement follows the international EEG 10/20 system.
Study: NCT06259435

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual diet
Description: Subjects will follow time-restricted eating of the usual diet
Study: NCT06194461

Intervention type: BIOLOGICAL
Intervention: AZD5851
Description: Safety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.
Study: NCT05386212

Intervention type: DEVICE
Intervention: web app healthcare instructions for relieving back pain
Description: This study designed web-based dynamic pain relief instructions for women with spinal compression fractures.

Intervention type: DEVICE
Intervention: web app healthcare instructions for relieving back pain
Description: This study designed web-based dynamic pain relief instructions for women with spinal compression fractures.
Study: NCT06459882

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercises
Description: Patients in the intervention group received 30-minute progressive relaxation exercises for 6 weeks
Study: NCT05879575

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: weight training
Description: Pregnant women assigned to the intervention group will receive online weight training sessions twice a week, for 60 minutes per session, from the 16th to the 36th week of pregnancy. The Pelvic Girdle Questionnaire will be used to assess the condition of pelvic girdle pain during pregnancy, and to analyze whether weight training can improve this problem. Pelvic floor muscle structure will also be analyzed by pelvic ultrasound to determine whether it has been altered by weight training, leading to an improvement in pain.
Study: NCT06150794

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excimer laser
Description: Excimer laser will be started at a dose of 300 mj/cm2 and increases 50-100 mj/cm2 each session. The aim of treatment is to deliver a dose that induces visible redness in the psoriatic lesion (supra-erythematous dose), but not induce a blister.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate Injection
Description: A ring block with 0.5 mL plain lignocaine (2%) will be administered in the web spaces on either side of the digit, followed by a 2.5-mg intramatrical methotrexate injection into each side of the nail at a point 2.5 mm proximal and lateral to the junction of proximal and lateral nail folds.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate Injection
Description: A ring block with 0.5 mL plain lignocaine (2%) will be administered in the web spaces on either side of the digit, followed by a 2.5-mg intramatrical methotrexate injection into each side of the nail at a point 2.5 mm proximal and lateral to the junction of proximal and lateral nail folds.
Study: NCT04684381

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-glutamine
Description: Pharmacokinetic study
Study: NCT05363384

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT-L01
Description: FDC tablet, single dose, oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin Benzoate 25 mg
Description: Alogliptin Benzoate 25 mg, oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin HCl XR 1,000 mg
Description: Metformin HCl XR 1,000 mg, oral administration
Study: NCT04432311

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Binge Focused Therapy (BFT)
Description: The BFT group will be provided Binge Focused Therapy, a group-based, guided-self help intervention. Participants in this group will attend three online group sessions spread over six weeks (Week 1, Week 2, and Week 6) and complete homework between sessions. Following Session 3, there is a four week period where participants complete self-guided check-ins once per week to monitor continued progress and/or signs of relapse.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT Unguided Self Help (CBT USH)
Description: The CBT USH group will be provided with the book, Overcoming Binge Eating by C. Fairburn, which is a well-established self-help book used to help individuals understand binge eating and control binge eating behaviours. After participants receive the book, they will have 10 weeks to read it and work through the exercises provided in the book.
Study: NCT05297825

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vegan diet
Description: Healthy vegan diet.
Study: NCT06322511

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dialogical Family Guidance (DFG)
Description: DFG is family intervention including six meetings with family members. The individual needs and questions of each family are discussed and issues parents bring up are seemed as important.
Study: NCT05810415

Intervention type: DIAGNOSTIC_TEST
Intervention: Renin levels and lactic acid levels
Description: Sampling of blood for measuring renin and lactate
Study: NCT05241470

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ST-100 Ophthalmic Solution
Description: One drop in each eye twice a day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ST-100 Ophthalmic Solution
Description: One drop in each eye twice a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Ophthalmic Solution
Description: One drop in each eye twice a day
Study: NCT05396885

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anitocabtagene-autoleucel
Description: Anitocabtagene-autoleucel-directed CAR T-cell therapy using a novel, synthetic binding domain, called a D-domain
Study: NCT05080348

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine iPACK Injection
Description: Injection of 20mL of 0.25% Ropivacaine with 1:400,000 Epinephrine between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Normal Saline iPACK Injection
Description: Injection of 20mL of 0.9% Normal Saline between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles
Study: NCT05719909

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: 8 sessions of web-based cognitive training

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Training
Description: 8 sessions of web-based sham training
Study: NCT06194461

Intervention type: BIOLOGICAL
Intervention: AZD0754
Description: Safety follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729.
Study: NCT05920538

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicardipine
Description: Subcutaneous infiltrate drug at puncture site by ultrasound-guided
Study: NCT05297825

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Omnivore diet
Description: Healthy omnivore diet.
Study: NCT05478447

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vibration
Description: whole-body vibration, and tendon vibrations will be applied to the human body
Study: NCT05920538

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Subcutaneous infiltrate NSS at puncture site by ultrasound-guided
Study: NCT06506877

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Implementation of Cognitive Risk Calculator (RC) and Brief Assessment of Cognitive Health (BACH)
Description: Enrolled providers will have access to two cognitive screening tools during the active phase. The first tool is a Cognitive Risk-Calculator (RC), integrated into the Electronic Health Record, to help providers identify patients who are at high risk of exhibiting cognitive decline. The second tool is a computerized cognitive screening tool, the Brief Assessment of Cognitive Health (BACH), which patients complete independently. Results are automatically entered into the patient's medical record, along with patient-specific flags for concerns about depression and/or sleep disorder. The purpose of these tools is to facilitate cognitive screening and treatment for factors that may be contributing to cognitive decline.
Study: NCT06176508

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10374
Description: Administered orally QD for 16 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10374
Description: Administered orally QD for 16 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HS-10374-matched placebo tablets
Description: Administered orally QD for 16 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tofacitinib 5Mg Tab,Oral
Description: Administered orally BID for 16 weeks
Study: NCT05391308

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-polysomnography mesurement
Description: Leg fluid volume (bioelectrical impedance), neck circumference (tape measure), neck volume (3D scanner), time spent sitting down (self-reporting)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Polysomnography measure
Description: Apnea-Hypopnea Index

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-polysomnography measurements
Description: Leg fluid volume (bioelectrical impedance), neck circumference (tape measure), neck volume (3D scanner)
Study: NCT03518333

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Injection of adipose derived cells into penis
Description: Injection of Icellator-derived cells

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Injection of adipose derived cells into penis
Description: Injection of Icellator-derived cells
Study: NCT05855668

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CBT
Description: 12 weeks of group CBT for AUD or CUD

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CBT
Description: 12 weeks of group CBT for AUD or CUD
Study: NCT05596916

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High frequency of stretching exercise
Description: After the randomization and evaluations, the selected postural stretching exercises will be taught to both groups in the clinic, and then a brochure will be given to the participants and they will be asked to practice these exercises at home.~In the experimental group, the exercises will be applied at the specified time and frequency, 5 days a week.~Participants will be given an Exercise Diary and exercise tracking will be provided by calling the participants once a week. The exercises will be done for 6 weeks. Participants will be evaluated twice, before and end of the treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low frequency of stretching exercise
Description: After the randomization and evaluations, the selected postural stretching exercises will be taught to both groups in the clinic, and then a brochure will be given to the participants and they will be asked to practice these exercises at home.~In the experimental group, the exercises will be applied at the specified time and frequency, 3 days a week.~Participants will be given an Exercise Diary and exercise tracking will be provided by calling the participants once a week. The exercises will be done for 6 weeks. Participants will be evaluated twice, before and end of the treatment.
Study: NCT06018766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LAM-001
Description: LAM-001 administered via dry powder inhaler

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered via dry powder inhaler
Study: NCT05837416

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: blue®m Gel
Description: Oxygen will be released after application Oxygen Releasing Oral Gel (blue®m gel) creating a partially high oxygen pressure (pO2), which aids in restoring the micro-environment for a healthy oral cavity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBF GINGIVAL GEL®
Description: Anti-oxidant gel (Nano-emulsion complex propolis and vitamin C - NBF GINGIVAL GEL®) is a nano bio fusion gel containing propolis, nano vitamin C, E and herb extract

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: COE-PAK™
Description: It is non eugenol periodontal dressing. It is supplied in two tubes, the contents of which are mixed immediately before use. One tube contains zinc oxide, oil, a gum, and lorothidol. The other tube contains liquid coconut fatty acids thickened with colophony resin and chlorothymol
Study: NCT06442215

Intervention type: OTHER
Intervention: Data collection
Description: Collection of preoperative demographic, clinical, and radiological variables from patients who meet the inclusion criteria in order to identify possible risk factors for suboptimal surgical treatment
Study: NCT05160818

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
Description: intervention description see above

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
Description: intervention description see above
Study: NCT06394453

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: enteral feeding with mother milk or human donor breast milk
Description: The experimental group will start enteral feeding with mother milk or human donor breast milk if mother milk is not accesible during the first day of therapeutic hypothermia.
Study: NCT06177093

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MR Linac delivered Radiotherapy
Description: All radiotherapy will be delivered on the MR-linac. The whole prostate will receive 30 Gy in 5 fractions and the dominant lesion plus intra-prostatic margin will receive an isotoxic 45 Gy prescription.
Study: NCT06508476

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Amnion Chorion membrane
Description: it is a placental allograft.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: connective tissue graft
Description: it is an autograft
Study: NCT00313976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Description: 250 micrograms every other day, subcutaneously for 104 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Description: 2x250 micrograms every other day, subcutaneously for 104 weeks
Study: NCT04986280

Intervention type: DIAGNOSTIC_TEST
Intervention: [18F]PSMA-1007
Description: PSMA PET/CT using the intervention.
Study: NCT04887389

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nano Silver Fluoride varnish
Description: Nano Silver Fluoride(5%) is a new experimental formulation containing silver nanoparticles, chitosan and fluoride combines preventive and antimicrobial properties. It is a yellow solution and safe to be used in humans

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nano-hydroxyapatite varnish
Description: nano-hydroxyapatite (10%) has antibacterial effect, higher solubility, surface energy and bioactivity and its structure is similar to dental apatite.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium Fluoride Varnish
Description: Fluoride varnish (5%) applied every six months is effective in preventing caries in the primary and permanent dentition of children and adolescents
Study: NCT06013436

Intervention type: DRUG
Intervention: Autologous serum tears combined with 0.05% cyclosporin eye drop
Description: All patients administrated autologous serum tears twelve times daily（per hour） and 0.05% cyclosporin eye drop twice times daily in each eye for 12 weeks.
Study: NCT06198855

Intervention type: DEVICE
Intervention: QMon-20 device
Description: Automatic Blood pressure measurement with QMon-20 device in the waiting room for 20 minutes every 5 minutes.

Intervention type: DEVICE
Intervention: QMon-20 device
Description: Automatic Blood pressure measurement with QMon-20 device in the waiting room for 20 minutes every 5 minutes.
Study: NCT04454736

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Amateur Group Singing
Description: 45-minute singing session led by a professional choirmaster without a therapeutic background once a week

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Amateur Group Singing
Description: 45-minute singing session led by a professional choirmaster without a therapeutic background once a week

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Professional Group Singing
Description: 120-minute singing session led by a professional choirmaster without a therapeutic background three times a week. Assessments take place twice a week.
Study: NCT05951712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simethicone 150mg
Description: Impact of simethicone on the mucosal visibility of stomach and duodenum

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N Acetyl cysteine 600mg
Description: Impact of N Acetyl cysteine on the mucosal visibility of stomach and duodenum

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simethicone 150mg plus N Acetyl cysteine 600 mg
Description: Impact of simethicone plus N Acetyl cysteine on the mucosal visibility of stomach and duodenum
Study: NCT05091840

Intervention type: OTHER
Intervention: oximetry monitoring
Description: monitoring oximetry in both groups using the INVOS™ system 5100C Oximeter
Study: NCT05951712

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Impact of water on the mucosal visibility of stomach and duodenum
Study: NCT06137872

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Group
Description: Pregnant women who came to the hospital for non-stress testing were met and informed about the study. The procedure was applied for non-stress testing. In the music group, the pregnant woman, who was assigned to the next group according to randomization during the non-stress test, was allowed to listen to music with disposable headphones for at least 20 minutes until the procedure was completed. At the same time, the mother will be asked to close her eyes and be relaxed. Headphones used to prevent infection were given to the pregnant woman as a gift at the end of the procedure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Pregnant women who came to the hospital for non-stress testing were met and informed about the study. The procedure was applied for non-stress testing. During the non-stress test, routine non-stress test was performed on the pregnant control group, which was assigned to the next group according to randomization.
Study: NCT04817293

Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire SSD-12 and EQ5D5L

Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire SSD-12 and EQ5D5L

Intervention type: OTHER
Intervention: medical consultation
Description: Medical consultation during the visit with data collection
Study: NCT05616585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic (PK)- Controlled Feeding Diet
Description: Pharmacokinetic- single-day isocaloric meals of beef, potatoes, chicken, whole wheat bread, corn, cheese, yogurt, and oats with blood and urine samples taken at Time Zero and every hour (blood) or two hours (urine) after eating, over 10 hours; and at 24 hr.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dose Response (DR)- Controlled Feeding Diet
Description: Dose Response-3 level, six days controlled feeding study with assignment to either beef/whole wheat bread, chicken/potato, salmon/corn, cheese/soybeans, or yogurt/oats within a standard diet at zero, medium, and high doses for 6 days.